Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide

Toxicology and Applied Pharmacology

Volumn 278, Issue 1, 2014, Pages 9-15

  Marini, Sara ^a   Buonanno, Giorgio ^a,b   Stabile, Luca ^a   Ficco, Giorgio ^a  

^a UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Alveolar and tracheobronchial particle dose; Electronic cigarette; Exhaled nitric oxide; Short term effect; Tobacco cigarette; Ultrafine particles

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE; NITRIC OXIDE;

AEROSOL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPIRED AIR; HUMAN; INHALATION; LUNG ALVEOLUS; PARTICLE SIZE; RESPIRATORY FUNCTION; SMOKING; TOBACCO; TRACHEOBRONCHIAL TREE;

ALVEOLAR AND TRACHEOBRONCHIAL PARTICLE DOSE; ELECTRONIC CIGARETTE; EXHALED NITRIC OXIDE; SHORT-TERM EFFECT; TOBACCO CIGARETTE; ULTRAFINE PARTICLES;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; BREATH TESTS; DRUG DELIVERY SYSTEMS; ELECTRONICS; EQUIPMENT DESIGN; EXHALATION; FEMALE; HUMANS; LUNG; MALE; NICOTINE; NICOTINIC AGONISTS; NITRIC OXIDE; PARTICLE SIZE; PARTICULATE MATTER; SMOKING; TIME FACTORS; TOBACCO PRODUCTS; VOLATILIZATION; YOUNG ADULT;

EID: 84899859806     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.04.004     Document Type: Article

References (69)

1. Ashutosh K. Nitric oxide and asthma: a review. Curr. Opin. Pulm. Med. 2000, 6:21-25.
2. ATS/ERS American Thoracic Society, European Respiratory Society. Recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am. J. Respir. Crit. Care Med. 2005, 171:912-930.
3. Bahna S.L. Should exhaled nitric oxide measurement be part of routine asthma management?. Ann. Allergy Asthma Immunol. 2012, 109:289-291.
4. Baker R. Smoke generation inside a burning cigarette: Modifying combustion to develop cigarettes that may be less hazardous to health. Prog. Energy Combust. Sci. 2006, 32:373-385.
5. Balfour-Lynn I.M., Laverty A., Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch. Dis. Child. 1996, 75:319-322.
6. Bullen C., McRobbie H., Thornley S., Glover M., Lin R., Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob. Control. 2010, 19:98-103.
7. Buonanno G., Giovinco G., Morawska L., Stabile L. Tracheobronchial and alveolar dose of submicrometer particles for different population age groups in Italy. Atmos. Environ. 2011, 45:6216-6224.
8. Buonanno G., Morawska L., Stabile L., Wang L., Giovinco G. A comparison of submicrometer particle dose between Australian and Italian people. Environ. Pollut. 2012, 169:183-189.
9. Buonanno G., Marks G., Morawska L. Health effects of daily airborne particle dose in children: direct association between personal dose and respiratory health effects. Environ. Pollut. 2013, 180:246-250.
10. Burtscher H. Physical characterization of particulate emissions from diesel engines: a review. J. Aerosol Sci. 2005, 36:896-932.
11. Caponnetto P., Russo C., Polosa R. Smoking cessation: present status and future perspectives. Curr. Opin. Pharmacol. 2012, 12:229-237.
12. Caponnetto P., Russo C., Bruno C.M., Alamo A., Amaradio M.D., Polosa R. Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch. Chest Dis. 2013, 79:12-19.
13. Cobb N.K., Byron M.J., Abrams D.B., Shields P.G. Novel Nicotine Delivery Systems and Public Health: The Rise of the "E-Cigarette". Am. J. Public Health 2010, 100:2340-2342.
14. Crawford T.V., McGrowder D.A., Barnett J.D., McGaw B.A., McKenzie I.F., James L.G. Tobacco-Related Chronic Illnesses: A Public Health Concern for Jamaica. Asian Pac. J. Cancer Prev. 2012, 13:4733-4738.
15. Cremona G., Higenbottam T., Borland C., Mist B. Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity. QJM 1994, 87:547-551.
16. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50years' observations on male British doctors. Br. Med. J. 2004, 328:1519-1528.
17. Dotsch J., Demirakca S., Terbrack H.G., Huls G., Rascher W., Kuhl P.G. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur. Respir. J. 1996, 9:2537-2540.
18. Etter J.F. Electronic cigarettes: a survey of users. BMC Public Health 2010, 10.
19. Etter J.F., Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106:2017-2028.
20. Etter J.F., Bullen C., Flouris A.D., Laugesen M., Eissenberg T. Electronic nicotine delivery systems: a research agenda. Tob. Control. 2011, 20:243-248.
21. Fiore M.C., Jaén C.R., Baker T.B., Bailey W.C., Benowitz N., Curry S.J. Treating tobacco use and dependence: 2008 update. Clinical practice guideline 2008, U.S. Department of Health and Human Services, Public Health Service, Rockville (MD).
22. Flouris A.D., Chorti M.S., Poulianiti K.P., Jamurtas A.Z., Kostikas K., Tzatzarakis M.N., Hayes A.W., Tsatsaki A.M., Koutedakis Y. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal. Toxicol. 2013, 25:91-101.
23. Foulds J., Veldheer S., Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int. J. Clin. Pract. 2011, 65:1037-1042.
24. Fuoco F.C., Buonanno G., Stabile L., Vigo P. Influence parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ. Pollut. 2014, 184:523-529.
25. Geiss O., Kotzias D. Institute for Health and Consumer Protection. EUR 22783 EN 2007.
26. Gennimata S.A., Palamidas A., Kaltsakas G., Tsikrika S., Vakali S., Gratziou C., Koulouris N. Acute effect of e-cigarette on pulmonary function in healthy subjects and smokers. Eur. Respir. Soc. Abstr. 2012, P1053.
27. Gormley P.G., Kennedy M. Diffusion from a stream flowing through a cylindrical tube. Proc. R. Ir. Acad. 1949, LII:163-169.
28. Grasemann H., Michler E., Wallot M., Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr. Pulmonol. 1997, 24:173-177.
29. Grasemann H., Ioannidis I., Tomkiewicz R.P., Groot H.d., Rubin B.K., Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 1998, 78:49-53.
30. Haussermann S., Kappeler D., Schmidt A., Siekmeier R. Fractional exhaled nitric oxide in clinical trials: an overview. Adv. Exp. Med. Biol. 2013, 788:237-245.
31. Helen A., Krishnakumar K., Vijayammal P.L., Augusti K.T. Antioxidant effect of onion oil (Allium cepa. Linn) on the damages induced by nicotine in rats as compared to alpha- tocopherol. Toxicol. Lett. 2000, 116:61-68.
32. Hueglin C., Scherrer L., Burtscher H. An accurate, continuously adjustable dilution system (1:10 to 1:10 4) for submicron aerosols. J. Aerosol Sci. 1997, 28:1049-1055.
33. Iho S., Tanaka Y., Takauji R., Kobayashi C., Muramatsu I., Iwasaki H., Nakamura K., Sasaki Y., Nakao K., Takahashi T. Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kB. J. Leukoc. Biol. 2003, 74:942-951.
34. Ingebrethsen B.J., Cole S.K., Alderman S.L. Electronic cigarette aerosol particle size distribution measurements. Inhal. Toxicol. 2012, 24:976-984.
35. International Agency for Research on Cancer IARC: Outdoor air pollution a leading environmental cause of cancer deaths, Lyon/Geneva, 17 October 2013 2013.
36. International Commission on Radiological Protection (ICRP) Human Respiratory Tract Model for Radiological Protection: A Report of a Task Group of the International Commission on Radiological Protection 1994, 1-482. Elsevier Science Ltd., Oxford, U.K.
37. Johnson T., Caldow R., Pöcher A., Mirme A., Kittelson D. A new electrical mobility particle sizer spectrometer for engine exhaust particle measurements. SAE Technical Papers 2004.
38. Kharitonov S.A., Barnes P.J. Exhaled biomarkers. Chest 2006, 130:1541-1546.
39. Kharitonov S.A., Robbins R.A., Yates D., Keatings V., Barnes P.J. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 1995, 152:609-612.
40. Leung J.M., Sin D.D. Biomarkers in airway diseases. Can. Respir. J. 2013, 20:180-182.
41. Loveless M.O., Phillips C.R., Giraud G.D., Holden W.E. Decreased exhaled nitric oxide in subjects with HIV infection. Thorax 1997, 52:185-186.
42. Lundberg J.O., Nordvall S.L., Weitzberg E., Kollberg H., Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch. Dis. Child. 1996, 75:323-326.
43. Malinovschi A., Janson C., Holmkvist T., Norback D., Merilainen P., Hogman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur. Respir. J. 2006, 28:339-345.
44. McCauley L., Markin C., Hosmer D. An unexpected consequence of electronic cigarette use. Chest 2012, 141:1110-1113.
45. McQueen A., Tower S., Sumner W. Interviews with 'vapers': implications for future research with electronic cigarettes. Nicotine Tob. Res. 2011, 13:860-867.
46. Min J.-y, Min K.-b Cadmium, smoking, and reduced levels of exhaled nitric oxide among US adults. Int. J. Hyg. Environ. Health 2014, 217:323-327.
47. Moline J.M., Golden A.L., Highland J.H., Wilmarth K.R., Kao A.S. Health effects evaluation of theatrical smoke, haze and pyrotechnics. Prepared for Actor's Equity Pension and Health Trust Funds 2000.
48. Moolgavkar S.H., Holford T.R., Levy D.T., Kong C.Y., Foy M., Clarke L., Jeon J., Hazelton W.D., Meza R., Schultz F., McCarthy W., Boer R., Gorlova O., Gazelle G.S., Kimmel M., McMahon P.M., de Koning H.J., Feuer E.J. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J. Natl. Cancer Inst. 2012, 104:541-548.
49. Ozkan M., Dweik R.A., Laskowski D., Arroliga A.C., Erzurum S.C. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung 2001, 179:233-243.
50. Persson M.G., Zetterstrom O., Agrenius V., Ihre E., Gustafsson L.E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994, 343:146-147.
51. Polosa R., Caponnetto P., Morjaria J.B., Papale G., Campagna D., Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011, 11.
52. Rengasamy A., Johns R.A. Regulation of nitric oxide synthase by nitric oxide. Mol. Pharmacol. 1993, 44:124-128.
53. Riley M.S., Porszasz J., Miranda J., Engelen M.P., Brundage B., Wasserman K. Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis. Chest 1997, 111:44-50.
54. Saito J., Inoue K., Sugawara A., Yoshikawa M., Watanabe K., Ishida T., Ohtsuka Y., Munakata M. Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren. J. Allergy Clin. Immunol. 2004, 114:512-516.
55. Schilling J., Holzer P., Guggenbach M., Gyurech D., Marathia K., Geroulanos S. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur. Respir. J. 1994, 7:467-471.
56. Schripp T., Markewitz D., Uhde E., Salthammer T. Does e-cigarette consumption cause passive vaping?. Indoor Air 2013, 23:25-31.
57. Siegel M.B., Tanwar K.L., Wood K.S. Electronic cigarettes as a smoking-cessation tool results from an online survey. Am. J. Prev. Med. 2011, 40:472-475.
58. Smith C.J., Livingston S.D., Doolittle D.J. An international literature survey of "IARC group I carcinogens" reported in mainstream cigarette smoke. Food Chem. Toxicol. 1997, 35:1107-1130.
59. Smith C.J., Perfetti T.A., Garg R., Hanschb C. IARC carcinogens reported in cigarette mainstream smoke and their calculated log P values. Food Chem. Toxicol. 2003, 41:807-817.
60. Stabile L., Trassierra C.V., Dell'Agli G., Buonanno G. Ultrafine Particle Generation through Atomization Technique: The Influence of the Solution. Aerosol Air Qual. Res. 2013, 13:1667-1677.
61. Su Y., Han W., Giraldo C., Li Y.D., Block E.R. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 1998, 19:819-825.
62. US Department of Health & Human Services The Health Consequences of Smoking: A Report of the Surgeon General. DHHS Publication No. (CDC) 88-8406 1988.
63. Vakali S., Tsikrika S., Gennimata A., Kaltsakas G., Palamidas A., Koulouris N., Gratziou C. Acute impact of a single e-cigarette smoking on symptoms, vital signs and air way inflammatory response. Eur. Respir. Soc. Abstr. 2012, P4050.
64. Vardavas C.I., Anagnostopoulos N., Kougias M., Evangelopoulou V., Connolly G.N., Behrakis P.K. Short-term pulmonary effects of using an e-cigarette: impact on respiratory flow resistance, impedance and exhaled nitric oxide. Chest 2012, 141:1400-1406.
65. Varughese S., Teschke K., Brauer M., Chow Y., Netten C.v., Kennedy S.M. Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am. J. Ind. Med. 2005, 47:411-418.
66. Wieslander G., Norback D., Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup. Environ. Med. 2001, 58:649-655.
67. World Health Organization WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package 2008, World Health Organization, Geneva, Switzerland, (Accessed at www.who.int/tobacco/mpower/2008/en/index.html).
68. Yates D.H., Breen H., Thomas P.S. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am. J. Respir. Crit. Care Med. 2001, 164:1043-1046.
69. Zhang Y., Sumner W., Chen D.R. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob. Res. 2013, 15:501-508.